BioNTech
-
Covid vaccine: Moderna sues Pfizer, BioNTech for patent infringement
Scroll Staff
-
Coronavirus: Pfizer, BioNTech begin trial to study Omicron-specific vaccine
Scroll Staff
-
Covid-19: Pfizer, BioNTech say booster dose of vaccine is effective against Omicron variant
Scroll Staff
-
Coronavirus: US fully approves Pfizer vaccine for children aged five to 11
Scroll Staff
-
Covid-19: Booster dose of Pfizer vaccine 95.6% effective against symptomatic infections, shows study
Scroll Staff
-
Coronavirus: Pfizer-BioNTech vaccine is 100% effective in 12 to 15 year olds, say companies
Scroll Staff
-
Coronavirus: Pfizer says its vaccine can be stored in normal freezers, seeks approval from FDA
Scroll Staff
-
Coronavirus: Pfizer-BioNTech warn against plans to delay second shot of vaccine
Scroll Staff
-
BioNTech says it can adapt its coronavirus vaccine in six weeks to tackle new strain
Scroll Staff
-
Coronavirus: UK medicine regulator issues anaphylaxis warning on Pfizer vaccine
Scroll Staff
-
Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator
Scroll Staff
-
Coronavirus: Pfizer applies for emergency use of its vaccine in US, approval expected mid-December
Scroll Staff
-
Covid-19: Pfizer-BioNTech vaccine delivery could start before Christmas if all goes well, says CEO
Scroll Staff
-
‘One step closer to ending pandemic’: Pfizer says its Covid-19 vaccine 90% effective in latest trial
Scroll Staff